EcoDrugPlus

Cyclin D1

Ensembl ID : ENSPSNG00000016389
Gene Symbol: CCND1
3 Cross references
277 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSPSNG00000014155
Gene Symbol: CDK1
3 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSPSNG00000011014
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSPSNG00000007800
Gene Symbol: CDK4
3 Cross references
212 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSPSNG00000006303
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSPSNG00000004540
Gene Symbol: CDK6
3 Cross references
198 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSPSNG00000008636
Gene Symbol: CDK7
3 Cross references
213 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSPSNG00000010493
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSPSNG00000001858
Gene Symbol: CDA
3 Cross references
224 Possible Orthologues:

Cytochrome P450 11b1, Mitochondrial

Ensembl ID : ENSPSNG00000016261
Gene Symbol: LOC116742421
2 Cross references
45 Possible Orthologues:

Cytochrome P450 3a29-Like

Ensembl ID : ENSPSNG00000013187
Gene Symbol: LOC116739882
2 Cross references
652 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSPSNG00000018242
Gene Symbol: CYP17A1
1 Cross references
210 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).